GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
WGS is expected to report earnings to fall 151.30% to 11 cents per share on August 18
Q2'25
Est.
$0.12
Q1'25
Missed
by $0.29
Q4'24
Beat
by $0.56
Q2'23
Missed
by $0.33
Q1'23
Missed
by $0.90
The last earnings report on April 30 showed earnings per share of -23 cents, missing the estimate of 5 cents. With 328.24K shares outstanding, the current market capitalization sits at 237.87M.